MedTrace Logo

Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy

NCT01257152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 754

Last updated 2016-04-20

No results posted yet for this study

Summary

A prospective, multicenter study:

* Primary objective: to assess the diagnostic yield of screening MRI compared to physical examination, mammography or ultrasonography in the detection of recurrence in patients treated with breast conserving therapy
* Secondary objective: to describe the size, type, grade, and nodal status of cancers seen only on MRI and to estimate the rate of benign biopsies and short interval follow-up induced only by MRI in this population.

Conditions

  • Breast Neoplasms
  • Neoplasm Recurrence, Local

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Woo Kyung Moon, M.D., Ph.D. · Department of Radiology, Seoul National University Hospital

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257152 on ClinicalTrials.gov